All In Biotech

Drug Trial Radar · NCT05529849

A Study to Assess the Safety, Tolerability and Pharmacokinetics of TCMCB07 in Single and Multiple Ascending Doses in Health Subjects

A Two-Part Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Subcutaneous Doses of TCMCB07 on Healthy Male and Female Subjects

Last checked: Nov 19, 2026Latest source record: Feb 21, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

76

Actual

Start

Jul 12, 2022

Primary completion

Dec 12, 2022

Study completion Feb 20, 2023

Sponsor

Lead sponsor
Endevica BioIndustry
Sponsor type
Industry
First posted
Sep 7, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 55 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study will test an experimental drug named TCMCB07 for the treatment of cancer cachexia. Cachexia is a syndrome characterized by weight loss, anorexia, weakness or lack of energy, and anemia. Cachexia occurs in many cancers, usually at the advanced stages of disease.

Conditions

  • Cachexia

Interventions

  • TCMCB07Drug

    Subcutaneous injection of TCMCB07

  • PlaceboDrug

    Matching subcutaneous placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of people with an Adverse Event AssessmentTime frame: 6 Months
  2. Number of participants with abnormal vital signsTime frame: 6 Months
  3. Number of people with abnormal laboratory test resultsTime frame: 6 Months
  4. Number of people with abnormal ElectrocardiogramsTime frame: 6 Months
  5. Number of people with abnormal physical examinationsTime frame: 6 Months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Quotient Sciences -- Miami, Inc.

    Miami, Florida

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.